1 – 10 of 40
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Dynamic assessment of proliferation to guide response-adapted therapy in the setting of neoadjuvant chemotherapy in ER+/HER2- breast cancer
Saghir, Hani LU ; Veerla, Srinivas LU
; Loman, Niklas
LU
and Kimbung, Siker
LU
(2026)
In Translational Oncology
63.
- Contribution to journal › Article
- 2025
-
Mark
Multi-omic profiling of squamous cell lung cancer identifies metabolites and related genes associated with squamous cell carcinoma
Staaf, Johan LU
; Ehinger, Daniel
LU
; Brunnström, Hans
LU
; Jönsson, Mats
LU
; Rosengren, Frida
LU
; Kotevska, Marija
LU
; Karlsson, Anna
LU
; Aine, Mattias
LU
; Frezza, Christian
and Planck, Maria
LU
, et al.
(2025)
In Molecular Oncology
19(12).
p.3806-3820
- Contribution to journal › Article
-
Mark
Stand-alone transcriptional immune response prediction in primary triple-negative breast cancer
Roostee, Suze LU
; Killander, Fredrika
LU
; Saghir, Hani
LU
; Nacer, Deborah F
LU
; Häkkinen, Jari
LU
; Sasiain, Iñaki
LU
; Veerla, Srinivas
LU
; Vallon-Christersson, Johan
LU
; Loman, Niklas
LU
and Ohlsson, Mattias
LU
, et al.
(2025)
In Cancer Research Communications
5(12).
p.2157-2174
- Contribution to journal › Article
-
Mark
Clinical potential of whole-genome data linked to mortality statistics in patients with breast cancer in the UK : a retrospective analysis
- Contribution to journal › Article
-
Mark
Capturing breast cancers’ copy-number landscape in routine pathology : Exploiting low-resolution, genome-wide sequencing to identify HRD and beyond
Kramer, C. J.H. ; van Wijk, L. M. ; Ruano, D. ; Gelpke-Vermeulen, S. ; van der Tuin, K. ; van der Stoep, N. ; van Wezel, T. ; Wesseling, J. ; Vallon-Christersson, J. LU
and Smit, V. T.H.B.M.
, et al.
(2025)
In British Journal of Cancer
133(8).
p.1199-1207
- Contribution to journal › Article
-
Mark
Timing of Adjuvant Chemotherapy After Surgical Resection for Non-small Cell Lung Cancer : A Target Trial Emulation Using Nationwide Swedish Registry Data
- Contribution to journal › Article
-
Mark
Copy number signatures in cervical samples enable early detection of high-grade serous ovarian carcinoma
Veerla, Srinivas LU
; Martin de la Fuente, Laura
LU
; Li, Minerva
LU
; Tang, Guyuan
; Ebbesson, Anna
LU
; D'Incalci, Maurizio
; Marchini, Sergio
; Mannarino, Laura
; Måsbäck, Anna
LU
and Malander, Susanne
LU
, et al.
(2025)
SCRM 2025 - the 7th Swedish Cancer Research Meeting
- Contribution to conference › Poster
-
Mark
Tertiary lymphoid structures in high-grade serous tubo-ovarian carcinoma : anatomical site matters
Westbom-Fremer, Sofia LU
; Tran, Lena
LU
; Ebbesson, Anna
LU
; Martin de la Fuente, Laura
LU
; Jönsson, Jenny-Maria
LU
; Kannisto, Päivi
LU
; Veerla, Srinivas
LU
and Hedenfalk, Ingrid
LU
(2025)
In Cancer Immunology Immunotherapy
74.
- Contribution to journal › Article
-
Mark
Evaluation of alternative prognostic thresholds for SP142 and 22C3 immunohistochemical PD-L1 expression in triple-negative breast cancer : results from a population-based cohort
Sigurjonsdottir, Gudbjörg LU ; De Marchi, Tommaso LU ; Ehinger, Anna LU
; Hartman, Johan
; Ullén, Susann
LU
; Leandersson, Karin
LU
; Bosch, Ana
LU
; Staaf, Johan
LU
; Killander, Fredrika
LU
and Niméus, Emma
LU
(2025)
In Breast Cancer Research and Treatment
210(2).
p.271-284
- Contribution to journal › Article
-
Mark
Genomic characterization of the HER2-enriched intrinsic molecular subtype in primary ER-positive HER2-negative breast cancer
Hohmann, Lennart LU
; Sigurjonsdottir, Kristin
LU
; Campos, Ana Bosch
LU
; Nacer, Deborah F.
LU
; Veerla, Srinivas
LU
; Rosengren, Frida
LU
; Reddy, Poojaswini Thimmaraya
LU
; Häkkinen, Jari
LU
; Nordborg, Nicklas
LU
and Vallon-Christersson, Johan
LU
, et al.
(2025)
In Nature Communications
16.
p.1-17
- Contribution to journal › Article